Last updated: June 5, 2026

Back to directory

TheraPanacea Annotate medical AI product profile

AI contouring module in TheraPanacea's ART-Plan environment for rapid organ-at-risk and lymph-node delineation before clinical review.

Screenshot of the official TheraPanacea Annotate product page
Medical imaging and radiology

Best fit

Cancer centers evaluating broad whole-body contouring support and cloud-based radiotherapy workflow acceleration with formal clinician validation.

Primary use case
AI-enhanced contouring for organs-at-risk, lymph nodes, treatment-planning segmentation, batch contouring, and radiotherapy preparation workflows
Audience
Radiation oncologists, dosimetrists, medical physicists, cancer-center AI committees, and radiotherapy operations leaders
Risk level
High
Pricing signal
Enterprise oncology pricing; verify current ART-Plan, Annotate, TumorBox, deployment, support, and regional authorization terms.
Official sources
4 official sources

Compare within workflow: Medical imaging and radiology · comparison shortlist · source index

Regulatory, privacy, evidence, and workflow lens

Product-specific review. These product-specific signals summarize what the cited sources imply before treating TheraPanacea Annotate as safe for a local clinical, operational, or research workflow.

Regulatory / FDAVerify exact ART-Plan module, FDA or CE status, intended-use labeling, geography, supported structures, and whether tumor or adaptive modules carry separate authorization.
PrivacyReview GDPR and HIPAA claims, cloud processing, DICOM metadata, retention, support access, user permissions, audit logs, and contractual PHI protections before sending radiotherapy images.
EvidenceCommission site-specific segmentation quality, contour edit burden, interobserver variability, anatomy-specific performance, guideline fit, and downstream treatment-plan effects.
WorkflowBest used as supervised contouring support with radiation oncologist validation, dosimetry editing, physicist QA, batch-workflow monitoring, and manual fallback for unsupported cases.

Where TheraPanacea Annotate fits

TheraPanacea describes Annotate as an AI-driven ART-Plan contouring solution for whole-body organs-at-risk and lymph nodes, with batch automation, cloud-based workflow, consensus-guideline alignment, and ongoing model evaluation; buyers should verify module-specific FDA or CE status and local deployment terms.

Not for: Autonomous treatment planning, accepting contours without expert validation, or assuming every geography, tumor model, modality, or ART-Plan module has the same clearance.

What to verify before using TheraPanacea Annotate

Source links

Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.

Related medical AI products